Nontuberculous mycobacteria (NTM) are increasingly observed in patients with chronic pulmonary disease such as cystic fibrosis (CF), alpha-1 antitrypsin deficiency, and chronic obstructive pulmonary disease (1, 2). This evidence concerns the gene SERPINA1 and cystic fibrosis.